Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
about
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report.Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.
P2860
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@ast
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@en
type
label
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@ast
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@en
prefLabel
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@ast
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@en
P2093
P2860
P356
P1433
P1476
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
@en
P2093
Akiko Okamoto
Atsushi Imai
Chikara Ohyama
Hayato Yamamoto
Shingo Hatakeyama
Takahiro Yoneyama
Takuya Koie
Yasuhiro Hashimoto
P2860
P2888
P356
10.1186/1756-0500-6-484
P577
2013-11-24T00:00:00Z
P5875
P6179
1017990656